MedPath

A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw

Not Applicable
Completed
Conditions
Chin Retrusion
Interventions
Device: Hyaluronic Acid Injectable Gel
Registration Number
NCT02559908
Lead Sponsor
Allergan
Brief Summary

This study will evaluate the safety and performance of VYC-25L hyaluronic acid injectable gel for the restoration and creation of facial volume in participants seeking to increase projection of the chin and/or jaw.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria

-Has chin retrusion.

Exclusion Criteria
  • Has ever received or is planning to receive permanent facial implants during the study.
  • Has tattoos, piercings, facial hair or scars that would interfere with visual assessments of the chin or jaw.
  • Has dentures or any device covering part of the palate or plans to undergo any dental procedure other than prophylaxis during the study.
  • Has undergone semipermanent dermal filler treatment to the chin or jaw within 36 months or is planning treatment during the study.
  • Has undergone any surgery of the chin or jaw area within 24 months or a planned surgery during the study.
  • Has undergone mesotherapy, cosmetic resurfacing, or botulinum toxin injections within 6 months or a planned treatment during the study.
  • Has experienced trauma to the chin and jaw area within 6 months.
  • Has been previously diagnosed with streptococcal disease.
  • Has a history of anaphylaxis or allergy to lidocaine, hyaluronic acid or streptococcal protein.
  • Has porphyria or untreated epilepsy.
  • Has active autoimmune disease.
  • Has current cutaneous or mucosal inflammatory or infectious processes, abscess, an unhealed wound, or a cancerous or pre-cancerous lesion.
  • Is on a concurrent regimen of lidocaine or structurally-related local anesthetics or is on a concurrent regimen of drugs that reduce or inhibit hepatic metabolism.
  • Has impaired cardiac conduction, severely impaired hepatic function, or severe renal dysfunction.
  • Is on an ongoing regimen of anti-coagulation therapy.
  • Is on an ongoing regimen of medications (eg, aspirin, ibuprofen) or other substances known to increase coagulation time (eg, herbal supplements with garlic or gingko biloba) within the past 10 days.
  • Has begun using any over-the-counter or prescription oral or topical, anti-wrinkle products below the subnasale within 30 days before enrollment or is planning to begin using such products during the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment Group_VYC-25LHyaluronic Acid Injectable GelVYC-25L injection into the chin and/or jaw areas on Day 1, volume determined by the investigator (up to 4.0 mLs) and repeat treatment if applicable
Control Group_No treatment then VYC-25LHyaluronic Acid Injectable GelNo treatment for 3 months followed by VYC-25L injection into the chin and/or jaw areas, volume determined by the investigator (up to 4.0 mLs) and repeat treatment if applicable.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in the Glabella-Subnasale-Pogonion (G-Sn-Pog) AngleBaseline, Month 3
Secondary Outcome Measures
NameTimeMethod
Percentage of Responders based on the Investigator's Assessment of Improvement in the Chin and Jaw Area using the 5-point Global Aesthetic Improvement Scale (GAIS)Month 3
Percentage of Responders based on the Participant's Assessment of Improvement in the Chin and Jaw Area using the 5-point GAISMonth 3

Trial Locations

Locations (10)

Joost Kroon Cosmetische Kliniek

🇳🇱

Amsterdam, Netherlands

Dermatogische Privatpraxis CentroDerm GmbH

🇩🇪

Wuppertal, Germany

Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH

🇩🇪

Darmstadt, Germany

Rotes Kreuz Krankenhaus Kassel Gemeinnützige GmbH Klinik für Plastische, Rekonstruktive und Ästhetische Chirurgie

🇩🇪

Kassel, Germany

Centre de Chirurgie Esthetique

🇫🇷

Toulouse, France

Dermatolgie Köln am Rhein

🇩🇪

Cologne, Germany

Kliniek Dokter Frodo Gaymans

🇳🇱

Amsterdam, Netherlands

Cabinet medical Solferino

🇫🇷

Paris, France

Hautzentrum Altenbochum - RuhrDERM Gemeinschaftspraxis Dr. med. Ardabili - Dr. med. Niesmann

🇩🇪

Bochum, Germany

Praxisgemeinschaft Theatiner46 Dres. Ogilvie und Dr. Bernd Schuster

🇩🇪

Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath